| P2093 | author name string | R Mark Meloche | |
| P2860 | cites work | Lessons learned from more than 1,000 pancreas transplants at a single institution | Q24541751 |
| | The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 |
| | Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen | Q28141785 |
| | Stabilisation of diabetic retinopathy following simultaneous pancreas and kidney transplant | Q30883178 |
| | Blood flow in the skin of type 1 diabetic patients before and after combined pancreas/kidney transplantation. | Q33214799 |
| | Five-year follow-up after clinical islet transplantation | Q33218078 |
| | Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement | Q33330718 |
| | Diabetic retinopathy and pancreas transplantation: a 3-year follow-up. | Q33430234 |
| | Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes | Q34091887 |
| | Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy | Q34231811 |
| | Pancreas transplantation: indications and consequences | Q34374126 |
| | Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. | Q34432925 |
| | Infection in organ-transplant recipients | Q34471508 |
| | Assessment of quality of life after simultaneous pancreas-kidney transplantation | Q34668311 |
| | Tumours after kidney transplantation | Q35065398 |
| | Skin cancers after transplantation | Q35128119 |
| | Beta-cell replacement for type I diabetes | Q35640221 |
| | An evidence-based analysis of simultaneous pancreas-kidney and pancreas transplantation alone | Q36280434 |
| | Current indications for pancreas or islet transplant | Q36347863 |
| | Pancreatic islet transplantation for treating diabetes | Q36349557 |
| | Maintenance immunosuppression regimens: conversion, minimization, withdrawal, and avoidance | Q36433166 |
| | Current status of pancreatic islet transplantation. | Q36475429 |
| | The long-term management of pancreas transplantation | Q36632969 |
| | Achieving and maintaining insulin independence in human islet transplant recipients | Q39268501 |
| | Microvascular function in human diabetes. A physiological perspective | Q40550044 |
| | Carotid intima media thickness decreases after pancreas transplantation | Q40649800 |
| | Quality of life after combined kidney-pancreas or kidney transplantation in diabetic patients with end-stage renal disease | Q41031633 |
| | Human islet transplantation: a preliminary report | Q41265958 |
| | Automated method for isolation of human pancreatic islets | Q42516583 |
| | Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure | Q42693684 |
| | Natural history of kidney graft survival, hypertrophy, and vascular function in end-stage renal disease type 1 diabetic kidney-transplanted patients: beneficial impact of pancreas and successful islet cotransplantation | Q43407252 |
| | Simultaneous pancreas-kidney transplantation in a large multicenter study: surgical complications | Q44604184 |
| | Consequences on beta-cell function and reserve after long-term pancreas transplantation | Q44779243 |
| | Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin-dependent) diabetes mellitus | Q45234379 |
| | Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes | Q45267369 |
| | Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. | Q46174852 |
| | The beneficial effects of pancreas transplant alone on diabetic nephropathy | Q46513447 |
| | A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year | Q46636291 |
| | Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus | Q46645995 |
| | Reversal of lesions of diabetic nephropathy after pancreas transplantation | Q47879758 |
| | Kidney and pancreas transplantation in the United States, 1995-2004. | Q50112848 |
| | Impact of transplantation on quality of life in patients with diabetes and renal dysfunction. | Q51970680 |
| | Analysis of United States (US) and non-US pancreas transplants reported to the United network for organ sharing (UNOS) and the international pancreas transplant registry (IPTR) as of October 2001. | Q53311178 |
| | International trial of the Edmonton protocol for islet transplantation. | Q54032399 |
| | Neuropathy profile of diabetic patients in a pancreas transplantation program | Q60681679 |
| | The optimization of large-scale density gradient isolation of human islets | Q72554083 |
| | Diabetic neuropathy 3 years after successful pancreas and kidney transplantation | Q72930791 |
| | Peripheral vascular disease after kidney-pancreas transplantation in diabetic patients with end-stage renal disease | Q73236176 |
| | Decreased surgical risks of pancreas transplantation in the modern era | Q73448096 |
| | Long-term effects of pancreatic transplantation on diabetic neuropathy | Q73929303 |
| | Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation | Q74650707 |
| | Cyclosporine-associated thrombotic microangiopathy in renal allografts | Q77829502 |
| | Long-term follow-up of diabetic polyneuropathy after simultaneous pancreas and kidney transplantation in type 1 diabetic patients | Q77958938 |
| | Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation | Q78724482 |
| | Influence of pancreas transplantation alone on native renal function | Q80110646 |
| | Beta-cell replacement therapy (pancreas and islet transplantation) for treatment of diabetes mellitus: an integrated approach | Q80532119 |
| | Prevention of bleeding after islet transplantation: lessons learned from a multivariate analysis of 132 cases at a single institution | Q81515309 |
| | Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation | Q81790383 |
| | Pancreas and islet transplantation in type 1 diabetes | Q82985963 |
| | Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects | Q83874715 |
| P433 | issue | 47 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type-1 diabetes | Q124407 |
| P304 | page(s) | 6347-6355 | |
| P577 | publication date | 2007-12-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Transplantation for the treatment of type 1 diabetes. | |
| P478 | volume | 13 | |